UC-San Francisco: Engineered Receptors Help the Immune System Home in On Cancer
November 16, 2024
November 16, 2024
SAN FRANCISCO, California, Nov. 16 (TNSres) -- The University of California San Francisco campus issued the following news release:
* * *
UCSF and University of Washington researchers developed synthetic receptors on the surface of immune cells that could make cancer immunotherapies more targeted.
* * *
Most cancer treatments - from chemotherapies to engineered immune cells - have a host of side effects, in large part because they affect health . . .
* * *
UCSF and University of Washington researchers developed synthetic receptors on the surface of immune cells that could make cancer immunotherapies more targeted.
* * *
Most cancer treatments - from chemotherapies to engineered immune cells - have a host of side effects, in large part because they affect health . . .